Literature DB >> 11198208

Reversible posterior leukoencephalopathy after combination chemotherapy.

J Honkaniemi1, V Kähärä, P Dastidar, M Latvala, A Hietaharju, T Salonen, L Keskinen, J Ollikainen, L Vähämäki, P Kellokumpu-Lehtinen, H Frey.   

Abstract

We describe a young woman with Burkitt's lymphoma, treated with intravenous adriamycine and cyclophosphamide and intrathecal cytarabine. She developed a reversible posterior leukoencephalopathy syndrome (RPLS) with typical MRI findings. Diffusion-weighted images during the first days after the onset of symptoms predicted a small irreversible lesion in the frontal lobe, verified on T2-weighted images 1 month later. The patient showed full recovery after high-dose steroid treatment.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11198208     DOI： 10.1007/s002340000482

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  9 in total

Review 1.  [White matter alterations after chemotherapy and radiation].

Authors:  A Simgen
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

2.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

3.  Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome.

Authors:  Maria Jose Abenza-Abildua; Blanca Fuentes; Domingo Diaz; Aranzazu Royo; Teresa Olea; Maria Jose Aguilar-Amat; Exuperio Diez-Tejedor
Journal:  BMJ Case Rep       Date:  2009-05-25

4.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

5.  [Postoperative occurrence of reversible posterior encephalopathy in a patient with Crohn's disease].

Authors:  S G Zipper; M Tischendorf; K Westphal
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 6.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

7.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09

8.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

9.  Reversible Posterior Leukoencephalopathy Syndrome Sometimes Could be Irreversible: A Case Following Tumor Lysis Syndrome in Childhood Burkitt's Lymphoma.

Authors:  Rui Zhang; Ling Jin; Hua Cheng; Jing Yang; Yan-Long Duan; Shuang Huang; Yong-Hong Zhang
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.